NCT06547853 Physical and Health Outcomes With ExeRcise in Cancer SURVIVORS
| NCT ID | NCT06547853 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Federal University of Alagoas |
| Condition | Breast Cancer Female |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2024-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-07-01 with a primary completion date of 2024-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the effect of a physical exercise intervention model on breast cancer survivors and their adherence. The sample will consist of 30 women with a primary diagnosis of breast cancer. The intervention will be carried out in a highly complex oncology center in Maceió-AL, Brazil, using the FITT components of the prescription: frequency (4 days a week), intensity (aerobic part through musical beats, subjective perception scale and resistance exercises through the number of maximum repetitions), the total time of each session will be 45 minutes. The intervention arms include combined exercise training and aerobic exercise (i.e., walking). Adherence to each intervention evaluated in the 12-week intervention cycle will be measured in each session.
Eligibility Criteria
Inclusion Criteria: 1. Women; 2. Adults; 3. confirmed diagnostic of breast cancer and with treatment completed (surgery, radiotherapy, or chemotherapy) within the previous six months. Exclusion Criteria: 1. present metastatic breast cancer; 2. any clinical condition that would make participating in the exercise intervention impossible.
Contact & Investigator
Jean Toscano, PhD
PRINCIPAL INVESTIGATOR
Federal University of Alagoas Institute of Physical Education and Sports
Frequently Asked Questions
Who can join the NCT06547853 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 90 Years, studying Breast Cancer Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06547853 currently recruiting?
Yes, NCT06547853 is actively recruiting participants. Contact the research team at jean.toscano@hotmail.com for enrollment information.
Where is the NCT06547853 trial being conducted?
This trial is being conducted at Alagoas, Brazil.
Who is sponsoring the NCT06547853 clinical trial?
NCT06547853 is sponsored by Federal University of Alagoas. The principal investigator is Jean Toscano, PhD at Federal University of Alagoas Institute of Physical Education and Sports. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.